Showing results (4101-4110 of 6,795) with videos related to
Sort By:
Pageof 680
Clinical Therapeutics|January 30, 2010
Pharmacokinetics of ciclesonide and desisobutyryl ciclesonide after administration via aqueous nasal spray or hydrofluoroalkane nasal aerosol compared with orally inhaled ciclesonide: an open-label, single-dose, three-period crossover study in healthy volunteersRuediger Nave, Rolf Herzog, Aziz Laurent, et al.Clinical Therapeutics|January 30, 2010
The effects of ketoconazole and rifampicin on the pharmacokinetics of mirodenafil in healthy Korean male volunteers: an open-label, one-sequence, three-period, three-treatment crossover studyKwang-Hee Shin, Bo-Hyung Kim, Tae-Eun Kim, et al.Clinical Therapeutics|January 30, 2010
Effects of hepatic impairment on the pharmacokinetics of nilotinib: an open-label, single-dose, parallel-group studyOphelia Q P Yin, Neil Gallagher, Chiaki Tanaka, et al.Clinical Therapeutics|December 4, 2003
Preclinical properties of budesonide: translation to the clinical settingDavid S PearlmanClinical Therapeutics|November 8, 2003
A review of combined hepatitis A and hepatitis B vaccination for travelersAlan M SpiraClinical Therapeutics|November 8, 2003
An open-label, prospective, observational study of the incidence of coronary artery disease in patients with HIV infection receiving highly active antiretroviral therapyGiuseppe Barbaro, Gabriella Di Lorenzo, Augusto Cirelli, et al.Clinical Therapeutics|November 8, 2003
Application of a data-mining technique to analyze coprescription patterns for antacids in TaiwanTzeng-Ji Chen, Li-Fang Chou, Shinn-Jang HwangClinical Therapeutics|September 27, 2003
Venlafaxine: a 2003 updateMary A Gutierrez, Glen L Stimmel, Janet Y AisoClinical Therapeutics|September 27, 2003
Two multicenter, randomized, single-blind, single-dose, crossover studies of specific sensory attributes of budesonide aqueous nasal spray and fluticasone propionate nasal sprayShailen R Shah, Christopher Miller, Ned Pethick, et al.Clinical Therapeutics|October 14, 2003
Multicenter retrospective assessment of thiazolidinedione monotherapy and combination therapy in patients with type 2 diabetes: comparative subgroup analyses of glycemic control and blood lipid levelsLeann Olansky, Albert Marchetti, Helen LauPageof 680